{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,27]],"date-time":"2026-10-27T14:24:40Z","timestamp":1793111080860,"version":"4.5.0"},"reference-count":34,"publisher":"Elsevier BV","issue":"9","license":[{"start":{"date-parts":[[2022,9,1]],"date-time":"2022-09-01T00:00:00Z","timestamp":1661990400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,9,1]],"date-time":"2022-09-01T00:00:00Z","timestamp":1661990400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,9,1]],"date-time":"2022-09-01T00:00:00Z","timestamp":1661990400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2022,9,1]],"date-time":"2022-09-01T00:00:00Z","timestamp":1661990400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2022,9,1]],"date-time":"2022-09-01T00:00:00Z","timestamp":1661990400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2022,9,1]],"date-time":"2022-09-01T00:00:00Z","timestamp":1661990400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2022,9,1]],"date-time":"2022-09-01T00:00:00Z","timestamp":1661990400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100000925","name":"National Health and Medical Research Council","doi-asserted-by":"publisher","award":["APP1080587"],"award-info":[{"award-number":["APP1080587"]}],"id":[{"id":"10.13039\/501100000925","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000925","name":"National Health and Medical Research Council","doi-asserted-by":"publisher","award":["APP1136197"],"award-info":[{"award-number":["APP1136197"]}],"id":[{"id":"10.13039\/501100000925","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001774","name":"University of Sydney","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001774","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","nmd-journal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Neuromuscular Disorders"],"published-print":{"date-parts":[[2022,9]]},"DOI":"10.1016\/j.nmd.2022.07.401","type":"journal-article","created":{"date-parts":[[2022,7,26]],"date-time":"2022-07-26T13:18:05Z","timestamp":1658841485000},"page":"707-717","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":6,"title":["A genetic basis is identified in 74% cases of paediatric hyperCKaemia without weakness presenting to a tertiary paediatric neuromuscular centre"],"prefix":"10.1016","volume":"32","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-1862-6306","authenticated-orcid":false,"given":"Wui-Kwan","family":"Wong","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Samantha J","family":"Bryen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adam","family":"Bournazos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joe","family":"Yasa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Frances","family":"Lemckert","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shobhana","family":"Bommireddipall","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Leigh B","family":"Waddell","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Manoj P","family":"Menezes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Richard","family":"Webster","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mark","family":"Davis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christina","family":"Liang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sandra T","family":"Cooper","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kristi J","family":"Jones","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.nmd.2022.07.401_bib0001","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1177\/0883073818758455","article-title":"Spectrum of neuromuscular disorders with HyperCKemia from a tertiary care pediatric neuromuscular center","volume":"33","author":"Al-Ghamdi","year":"2018","journal-title":"J Child Neurol"},{"key":"10.1016\/j.nmd.2022.07.401_bib0002","doi-asserted-by":"crossref","first-page":"805","DOI":"10.1002\/mus.23755","article-title":"Asymptomatic\/pauci-symptomatic creatine kinase elevations (hyperckemia)","volume":"47","author":"Silvestri","year":"2013","journal-title":"Muscl Nerve"},{"key":"10.1016\/j.nmd.2022.07.401_bib0003","doi-asserted-by":"crossref","first-page":"767","DOI":"10.1111\/j.1468-1331.2010.03012.x","article-title":"EFNS guidelines on the diagnostic approach to pauci- or asymptomatic hyperCKemia","volume":"17","author":"Kyriakides","year":"2010","journal-title":"Eur J Neurol"},{"key":"10.1016\/j.nmd.2022.07.401_bib0004","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1007\/s004150200010","article-title":"Retrospective study of a large population of patients with asymptomatic or minimally symptomatic raised serum creatine kinase levels","volume":"249","author":"Prelle","year":"2002","journal-title":"J Neurol"},{"key":"10.1016\/j.nmd.2022.07.401_bib0005","first-page":"514","article-title":"Electrodiagnosis and muscle biopsy in asymptomatic hyperckemia","volume":"126","author":"Kokotis","year":"2016","journal-title":"Int J Neurosci"},{"key":"10.1016\/j.nmd.2022.07.401_bib0006","doi-asserted-by":"crossref","first-page":"1585","DOI":"10.1212\/01.wnl.0000216144.69630.6e","article-title":"Diagnostic evaluation of clinically normal subjects with chronic hyperCKemia","volume":"66","author":"Fernandez","year":"2006","journal-title":"Neurology"},{"key":"10.1016\/j.nmd.2022.07.401_bib0007","first-page":"110","article-title":"Asymptomatic or minimally symptomatic hyperCKemia: histopathologic correlates","volume":"8","author":"Dabby","year":"2006","journal-title":"Isr Med Assoc J"},{"key":"10.1016\/j.nmd.2022.07.401_bib0008","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1097\/ALN.0b013e3181862a0d","article-title":"Muscle biopsy and in vitro contracture test in subjects with idiopathic HyperCKemia","volume":"109","author":"Malandrini","year":"2008","journal-title":"Anesthesiology"},{"key":"10.1016\/j.nmd.2022.07.401_bib0009","doi-asserted-by":"crossref","first-page":"1333","DOI":"10.1080\/00207450490476110","article-title":"Reconsidering idiopathic CK-elevation","volume":"114","author":"Finsterer","year":"2004","journal-title":"Int J Neurosci"},{"key":"10.1016\/j.nmd.2022.07.401_bib0010","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1002\/mus.10292","article-title":"Muscle biopsy in the evaluation of patients with modestly elevated creatine kinase levels","volume":"27","author":"Simmons","year":"2003","journal-title":"Muscl Nerve"},{"key":"10.1016\/j.nmd.2022.07.401_bib0011","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1017\/cjn.2017.286","article-title":"Next-generation sequencing to diagnose muscular dystrophy, rhabdomyolysis, and HyperCKemia","volume":"45","author":"Wu","year":"2018","journal-title":"Can J Neurol Sci"},{"key":"10.1016\/j.nmd.2022.07.401_bib0012","doi-asserted-by":"crossref","first-page":"S181","DOI":"10.1016\/j.nmd.2019.06.506","article-title":"100Impact of NGS on HyperCKemia diagnosis","volume":"29","author":"Marti","year":"2019","journal-title":"Neuromuscul Disord"},{"key":"10.1016\/j.nmd.2022.07.401_bib0013","doi-asserted-by":"crossref","DOI":"10.1212\/NXG.0000000000000352","article-title":"Next-generation sequencing approach to hyperCKemia: a 2-year cohort study","volume":"5","author":"Rubegni","year":"2019","journal-title":"Neurology Genetics"},{"key":"10.1016\/j.nmd.2022.07.401_bib0014","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1002\/mus.27448","article-title":"An integrated approach to the evaluation of patients with asymptomatic or minimally symptomatic hyperCKemia","volume":"65","author":"Gemelli","year":"2022","journal-title":"Muscl Nerve"},{"key":"10.1016\/j.nmd.2022.07.401_bib0015","series-title":"Aids to the examination of the peripheral nervous system","year":"1976"},{"key":"10.1016\/j.nmd.2022.07.401_bib0016","doi-asserted-by":"crossref","first-page":"368","DOI":"10.1136\/jmg.2006.047464","article-title":"Measurement of the clinical utility of a combined mutation detection protocol in carriers of Duchenne and Becker muscular dystrophy","volume":"44","author":"Taylor","year":"2007","journal-title":"J Med Genet"},{"key":"10.1016\/j.nmd.2022.07.401_bib0017","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1002\/acn3.51002","article-title":"Targeted gene panel use in 2249 neuromuscular patients: the Australasian referral center experience","volume":"7","author":"Beecroft","year":"2020","journal-title":"Ann Clin Translat Neurol"},{"key":"10.1016\/j.nmd.2022.07.401_bib0018","doi-asserted-by":"crossref","first-page":"991","DOI":"10.1016\/j.nmd.2015.10.010","article-title":"The 2016 version of the gene table of monogenic neuromuscular disorders (nuclear genome)","volume":"25","author":"Kaplan","year":"2015","journal-title":"Neuromuscul Disord"},{"key":"10.1016\/j.nmd.2022.07.401_bib0019","doi-asserted-by":"crossref","first-page":"872","DOI":"10.1038\/nature06884","article-title":"The complete genome of an individual by massively parallel DNA sequencing","volume":"452","author":"Wheeler","year":"2008","journal-title":"Nature"},{"key":"10.1016\/j.nmd.2022.07.401_bib0020","doi-asserted-by":"crossref","first-page":"1297","DOI":"10.1101\/gr.107524.110","article-title":"The genome analysis toolkit: A MapReduce framework for analyzing next-generation DNA sequencing data","volume":"20","author":"McKenna","year":"2010","journal-title":"Genom Res"},{"key":"10.1016\/j.nmd.2022.07.401_bib0021","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1038\/gim.2015.30","article-title":"Standards and guidelines for the interpretation of sequence variants: a joint consensus recommendation of the American College of Medical Genetics and Genomics and the Association for Molecular Pathology","volume":"17","author":"Richards","year":"2015","journal-title":"Genet Med"},{"key":"10.1016\/j.nmd.2022.07.401_bib0022","series-title":"Carnitine Palmitoyltransferase II Deficiency","author":"Wieser","year":"1993"},{"key":"10.1016\/j.nmd.2022.07.401_bib0023","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1001\/archneur.62.1.37","article-title":"Muscle carnitine palmitoyltransferase II deficiency: clinical and molecular genetic features and diagnostic aspects","volume":"62","author":"Deschauer","year":"2005","journal-title":"Archiv Neurol (Chicago)"},{"key":"10.1016\/j.nmd.2022.07.401_bib0024","doi-asserted-by":"crossref","first-page":"43","DOI":"10.3390\/life10040043","article-title":"Update review about metabolic myopathies","volume":"10","author":"Finsterer","year":"2020","journal-title":"Life"},{"key":"10.1016\/j.nmd.2022.07.401_bib0025","doi-asserted-by":"crossref","first-page":"1543","DOI":"10.1097\/01.LAB.0000098428.51765.83","article-title":"Carnitine palmitoyltransferase II deficiency: a clinical, biochemical, and molecular review","volume":"83","author":"Sigauke","year":"2003","journal-title":"Lab Invest"},{"key":"10.1016\/j.nmd.2022.07.401_bib0026","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1016\/S0960-8966(99)00015-2","article-title":"X-linked dilated cardiomyopathy and the dystrophin gene","volume":"9","author":"Ferlini","year":"1999","journal-title":"Neuromuscul Disord"},{"key":"10.1016\/j.nmd.2022.07.401_bib0027","doi-asserted-by":"crossref","first-page":"3168","DOI":"10.1161\/01.CIR.94.12.3168","article-title":"Myocardial involvement is very frequent among patients affected with subclinical Becker's muscular dystrophy","volume":"94","author":"Melacini","year":"1996","journal-title":"Circulation"},{"key":"10.1016\/j.nmd.2022.07.401_bib0028","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1016\/S0022-510X(97)00215-3","article-title":"Gly341Arg mutation indicating malignant hyperthermia susceptibility: specific cause of chronically elevated serum creatine kinase activity","volume":"154","author":"Monsieurs","year":"1998","journal-title":"J Neurol Sci"},{"key":"10.1016\/j.nmd.2022.07.401_bib0029","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1002\/mus.24749","article-title":"A novel therapeutic approach for LPIN1 mutation-associated rhabdomyolysis\u2013the Austrian experience","volume":"52","author":"Pichler","year":"2015","journal-title":"Muscl Nerve"},{"key":"10.1016\/j.nmd.2022.07.401_bib0030","first-page":"1","article-title":"Clinical efficacy of the enzyme replacement therapy in patients with late-onset Pompe disease: a systematic review and a meta-analysis","author":"Sarah","year":"2021","journal-title":"J Neurol"},{"key":"10.1016\/j.nmd.2022.07.401_bib0031","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1111\/imj.12710","article-title":"Macro-creatine kinase: a neglected cause of elevated creatine kinase","volume":"45","author":"Aljuani","year":"2015","journal-title":"Intern Med J"},{"key":"10.1016\/j.nmd.2022.07.401_bib0032","doi-asserted-by":"crossref","first-page":"2107","DOI":"10.37358\/RC.18.8.6483","article-title":"Macro creatine kinase (macro CK) in clinical practice","volume":"69","author":"Bojinca","year":"2018","journal-title":"Revista De Chimie"},{"key":"10.1016\/j.nmd.2022.07.401_bib0033","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1093\/clinchem\/29.1.201","article-title":"Macro creatine kinase types 1 and 2: clinical significance in neonates and children as compared with adults","volume":"29","author":"Wu","year":"1983","journal-title":"Clin Chem"},{"key":"10.1016\/j.nmd.2022.07.401_bib0034","doi-asserted-by":"crossref","first-page":"711","DOI":"10.1038\/ejhg.2009.25","article-title":"Genetic testing in asymptomatic minorsBackground considerations towards ESHG Recommendations","volume":"17","author":"Pascal","year":"2009","journal-title":"Eur J Human Genet"}],"container-title":["Neuromuscular Disorders"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0960896622006150?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0960896622006150?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,18]],"date-time":"2025-10-18T08:12:45Z","timestamp":1760775165000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0960896622006150"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,9]]},"references-count":34,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2022,9]]}},"alternative-id":["S0960896622006150"],"URL":"https:\/\/doi.org\/10.1016\/j.nmd.2022.07.401","relation":{},"ISSN":["0960-8966"],"issn-type":[{"value":"0960-8966","type":"print"}],"subject":[],"published":{"date-parts":[[2022,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"A genetic basis is identified in 74% cases of paediatric hyperCKaemia without weakness presenting to a tertiary paediatric neuromuscular centre","name":"articletitle","label":"Article Title"},{"value":"Neuromuscular Disorders","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.nmd.2022.07.401","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Crown Copyright \u00a9 2022 Published by Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}